Investigation Overview
May 19, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC), was announced concerning whether the takeover of Anacor Pharmaceuticals Inc. by Pfizer Inc for $99.25 per share is unfair to NASDAQ:ANAC stockholders. The investigation by a law firm concerns whether certain officers and directors of...
You must register (for free) or login to view the entire investigation.